Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

Clinical trial NCT05049473 · UNKNOWN

Trial details

NCT number: NCT05049473
Sponsor: PETHEMA Foundation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Mature B-Cell Leukemia Burkitt Type Burkitt Lymphoma (BL)Unclassifiable Lymphoma Between DCBL and BL

Start date: 2014-01-01
Primary completion: 2024-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.